| Identification | Back Directory | [Name]
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl | [CAS]
804518-63-6 | [Synonyms]
tunodafilo
4H-Pyrrolo[2,3-d]pyrimidin-4-one, 2-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-3,7-dihydro-5-methyl-7-propyl-
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl | [Molecular Formula]
C24H33N5O4S | [MDL Number]
MFCD28975335 | [MOL File]
804518-63-6.mol | [Molecular Weight]
487.61 |
| Chemical Properties | Back Directory | [Boiling point ]
678.6±65.0 °C(Predicted) | [density ]
1.32±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
7.14±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Yonkenafil is a phosphodiesterase type 5 (PDE5) inhibitor and can protect the neuronal networks from injury after a stroke. Yonkenafil can have a potential therapeutic effect on Alzheimer’s disease by modulating neurogenesis to improve cognitive function and improving the amyloid burden in mice. |
|
| Company Name: |
Pharma Affiliates
|
| Tel: |
172-5066494 |
| Website: |
http://m.is0513.com/ShowSupplierProductsList694812/0.htm |
|